מהפכה בפיתוח תרופות בארה"ב: הסוף לניסויים בבעלי חיים?

הערכה

The FDA has changed its regulations to allow alternatives to animal testing in drug development, including human cells, organ-on-a-chip technology, and computer models. This shift could reduce the number of animal experiments required and may affect Israeli researchers and companies that follow FDA standards. Animal testing will still be required when no suitable alternative exists, and safety standards remain unchanged. The practical impact depends on how broadly regulators accept these new methods.